Diagnostics

OncoHost Named Gold Winner in 2025 Merit Awards for Business in Research & DevelopmentOncoHost Named Gold Winner in 2025 Merit Awards for Business in Research & Development

OncoHost Named Gold Winner in 2025 Merit Awards for Business in Research & Development

BINYAMINA, Israel and CARY, N.C., July 9, 2025 /PRNewswire/ -- OncoHost, a technology company transforming the approach to precision medicine…

4 weeks ago
Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of DirectorsPalisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Figure: 1 Palisade Bio, Inc. Appoints Emil Chuang, MB BS FRACP to its Board of Directors Veteran clinical leader with…

4 weeks ago
Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida LawCelularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

Celularity & Fountain Life Announce Partnership to Deliver Stem Cell Therapies Under New Florida Law

Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025,…

4 weeks ago
The Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination IntegrityThe Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination Integrity

The Anosh Foundation Launches Global Oversight Initiative to Strengthen COVID-19 Testing and Vaccination Integrity

Nonprofit organization enhances international COVID response efforts with new compliance and quality assurance measures. Image of Dr. Anosh Ahmed CHICAGO,…

4 weeks ago
Pivotal Data Validates Diagnostic Equivalence of SCANLY Home OCT and In-Office OCT in Wet AMD ManagementPivotal Data Validates Diagnostic Equivalence of SCANLY Home OCT and In-Office OCT in Wet AMD Management

Pivotal Data Validates Diagnostic Equivalence of SCANLY Home OCT and In-Office OCT in Wet AMD Management

Manassas, Virginia--(Newsfile Corp. - July 9, 2025) - Notal Vision, a digital healthcare provider advancing remote patient monitoring in ophthalmology,…

4 weeks ago
Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 8, 2025 /PRNewswire/ -- The global biosensors market is projected to grow from USD 34.51 billion in…

4 weeks ago
Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

Biosensors Market worth $54.37 billion by 2030 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., July 8, 2025 /PRNewswire/ -- The global biosensors market is projected to grow from USD 34.51 billion in…

4 weeks ago
Circular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s DiseaseCircular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s Disease

Circular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s Disease

SAN DIEGO, July 8, 2025 /PRNewswire/ -- Circular Genomics, Inc., a global leader in circular RNA (circRNA) biomarkers for precision…

4 weeks ago
Circular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s DiseaseCircular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s Disease

Circular Genomics Receives $250K Investment from the Alzheimer’s Drug Discovery Foundation (ADDF) to Advance First-in-Class Circular RNA Blood-Based Biomarker Tests for the Early Detection of Alzheimer’s Disease

SAN DIEGO, July 8, 2025 /PRNewswire/ -- Circular Genomics, Inc., a global leader in circular RNA (circRNA) biomarkers for precision…

4 weeks ago
Healthcare’s $110B AI Surge Is Picking Up Speed–and It’s Just the BeginningHealthcare’s $110B AI Surge Is Picking Up Speed–and It’s Just the Beginning

Healthcare’s $110B AI Surge Is Picking Up Speed–and It’s Just the Beginning

USA News Group News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- As artificial intelligence…

4 weeks ago
Show more Posts
Show previous Posts